Novartis and Bristol Myers Squibb (BMS) are both asking a federal appeals court to overturn a lower court’s ruling that [...] …
Category: Providers
Tennessee covered entities must now submit claims data for all Boehringer Ingelheim (BI) 340B drugs filled by their in-house pharmacies [...] …
Oregon state senators late yesterday narrowly passed legislation to prohibit drugmakers from restricting 340B contract pharmacy access in the state. [...] …
Oregon state senators are pushing for competing amendments to a 340B contract pharmacy access bill that passed the state House; [...] …
AstraZeneca and the brand-name drug industry’s leading trade group have filed federal lawsuits challenging newly enacted 340B contract pharmacy access [...] …
Two Oklahoma Republican lawmakers are urging their colleagues to override Gov. Kevin Stitt’s (R) veto of a 340B contract pharmacy [...] …
Following a string of losses in federal courts, some drugmakers are now turning to state-level courts in an effort to [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. told a U.S. Senate subcommittee Tuesday that the 340B program [...] …
A federal judge’s decision to uphold the government’s authority to pre-approve drugmaker 340B rebate models has drawn praise from providers, [...] …